Published in
Elsevier, The Lancet Oncology, 10(19), p. 1360-1371, 2018
DOI: 10.1016/s1470-2045(18)30438-8
Links
Tools
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group
Journal article published in 2018 by
Giovanni Grignani 
,
Lorenzo D'Ambrosio ,
Ymera Pignochino,
Emanuela Palmerini,
Massimo Zucchetti,
Paola Boccone,
Sandra Aliberti,
Silvia Stacchiotti,
Rossella Bertulli,
Raimondo Piana,
Sara Miano,
Francesco Tolomeo,
Giulia Chiabotto,
Dario Sangiolo ,
Alberto Pisacane
and other authors.
,
Lorenzo D'Ambrosio ,
Ymera Pignochino,
Emanuela Palmerini,
Massimo Zucchetti,
Paola Boccone,
Sandra Aliberti,
Silvia Stacchiotti,
Rossella Bertulli,
Raimondo Piana,
Sara Miano,
Francesco Tolomeo,
Giulia Chiabotto,
Dario Sangiolo ,
Alberto Pisacane
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 